Exploitation of the Vβ8.2 T cell receptor in protection against experimental autoimmune encephalomyelitis using a live vaccinia virus vector

Journal of Immunology

Volumn 156, Issue 12, 1996, Pages 4940-4945

  Chunduru, Srinivas K ^a   Sutherland, Robyn M ^a,b   Stewart, Gail A ^a,c   Doms, Robert W ^a   Paterson, Yvonne ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c The College of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR; VIRUS VECTOR; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS; ANIMAL; CD4 LYMPHOCYTE COUNT; CYTOLOGY; FEMALE; GENE VECTOR; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE ACTIVATION; MALE; MOUSE STRAIN; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

ANIMALS; CD4 LYMPHOCYTE COUNT; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENETIC VECTORS; INTERLEUKIN-2; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED STRAINS; MYELIN BASIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; VACCINATION; VACCINIA VIRUS;

EID: 0029665430     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Offner, H., G. A. Hashim, and A. A. Vandenbark. 1991. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251: 430.
2. Howell, M. D., S. T. Winters, T. Olee, H. C. Powell, D. J. Carlo, and S. W. Brostoff. 1989. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668.
3. Vandenbark, A. A., G. Hashim, and H. Offner. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541.
4. Desquenne-Clark, L., T. R. Esch, L. Otvos, Jr., and E. Heber-Katz. 1991. T cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. USA 88:7219.
5. Acha-Orbea, H., D. J. Mitchell, L. Timmermann, D. C. Wraith, G. S. Tausch, M. K. Waldor, S. S. Zamvil, H. O. McDevitt, and L. Steinmann. 1988. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263.
6. Urban, J. L., V. Kumar, D. H. Kono, C. Gomez, S. J. Horvath, J. Clayton, D. G. Ando, E. E. Sercarz, and L. Hood. 1988. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577.
7. Owhashi, M., and E. Heber-Katz. 1989. Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein. J. Exp. Med. 168:2153.
8. Zamvil, S. S., D. J. Mitchell, N. E. Lee, A. C. Moore, M. K. Waldor, K. Sakai, J. B. Rothbard, H. O. McDevitt, L. Steinman, and H. Acha-Orbea. 1988. Predominant expression of a T cell receptor Vβ gene subfamily in autoimmune encephalitis. J. Exp. Med. 167:1586.
9. Hashim, G. A., A. A. Vandenbark, A. B. Galang, T. Diamanduros, E. Carvalho, J. Srinivasan, R. Jones, M. Vainiene, W. J. Morrison, and H. Offner. 1990. Antibodies specific for Vβ8 receptor peptide suppress experimental autoimmune encephalomyelitis. J. Immunol. 144:4621.
10. + cells in T cell receptor peptide-induced clonal unresponsiveness. Science 259:91.
11. Sun, D., Y. Qin, J. Chluba, J. T. Epplen, and H. Wekerle. 1988. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 332:843.
12. Lider, O., L. M. B. Santos, C. S. Y. Lee, P. J. Higgins, and H. L. Weiner. 1989. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. J. Immunol. 142:748.
13. + T cells in murine EAE. Science 256:1213.
14. -/- mice. Science 256: 1210.
15. + T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909.
16. Ben-Nun, A., H. Wekerle, and I. Cohen. 1981. Vaccination against autoimmune encephalomyelitis with T lymphocyte line cells reactive against myelin basic protein. Nature 292:60.
17. Moss, B., G. L. Smith, J. L. Gerin, and R. H. Purcell. 1984. Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature 311:67.
18. Cooney, E. L., A. C. Collier, P. D. Greenberg, R. N. Coombs, J. Zarling, D. E. Aarditti, M. C. Hoffman, S.-L. Hu, and L. Corey. 1991. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet 337:567.
19. Lathe, R., M. P. Kieny, P. Gerlinger, P. Clertant, I. Guizani, F. Cuzin, and P. Chambon. 1987. Tumor prevention and rejection with recombinant vaccinia. Nature 326:878.
20. Bernards, R., A. Destree, S. McKenzie, E. Gordon, R. A. Weinberg, and D. Panicali. 1987. Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector. Proc. Natl. Acad. Sci. USA 84: 6854.
21. Staerz, U. D., H.-G. Rammensee, J. D. Benedetto, and M. J. Bevan. 1985. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J. Immunol. 134:994.
22. Deibler, G. E., R. E. Martenson, and M. W. Kies. 1972. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Anal. Biochem. 2:139.
23. Zamvil, S. S., D. J. Mitchell, N. E. Lee, A. C. Moore, K. Kitamura, L. Steinman, and J. B. Rothbard. 1986. T cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324:258.
24. Zamvil, S. S., D. J. Mitchell, M. B Powell, K. Sakai, J. B. Rothbard, and L. Steinman. 1988. Multiple discrete encephlitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells. J. Exp. Med. 168:1181.
25. Kaye, J., S. Procelli, J. Tite, B. Jones, and C. A. Janeway, Jr. 1983. Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells. J. Exp. Med. 158:836.
26. Hedrick, S. M., L. A. Malis, T. T. Hecht, L. E. Samelson, D. L. Longo, E. Heber-Katz, and R. H. Schwartz. 1982. The fine specificity of antigen and Ia determinant recognition by T cell hybridoma clones specific for pigeon cytochrome c. Cell 30:141.
27. Earl, P. L., N. Cooper, and B. Moss. 1994. Preparation of cell cultures and vaccinia virus stocks. In Current Protocols in Molecular Biology. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Stohl, eds. Wiley Interscience, New York, pp. 16.16-16.19.
28. Smilek, D. E., D. C. Wraith, S. Hodgkinson, S. Dwivedy, L. Steinman, and H. O. McDevitt. 1991. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephlomyelitis. Proc. Natl. Acad. Sci. USA 88:9633.
29. Brown, F., G. C. Schild, and G. L. Ada. 1986. Recombinant vaccinia viruses as vaccines. Nature 319:549.
30. Bennink, J. R., and J. W. Yewdell. 1990. Recombinant vaccinia viruses for studying T lymphocyte specificity and function. Curr. Top. Microbiol. Immunol. 163: 153.
31. Yewdell, J. W., J. R. Bennink, and Y. Hosaka. 1988. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 239:637.
32. Yewdell, J. W., and J. R. Bennink. 1989. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 244:1072.
33. Nuchtern, J. G., J. S. Bonifacino, W. E. Biddison, and R. D. Klausner. 1989. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature 339:223.
34. Stevens, D. B., W. J. Karpus, K. E. Gould, and R. H. Swanborg. 1992. Studies of Vβ8 T cell receptor peptide treatment in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 37:123.
35. Buller, R. M. L., and G. J. Palumbo. 1991. Poxvirus pathogenesis. Microbiol. Rev. 55:80.
36. Fenner, F. 1989. Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign. Res. Virol. 140:465.
37. Henderson, D. A., and I. Arita. 1985. Utilization of vaccine in the global eradication of smallpox. In Vaccinia Viruses as Vectors for Vaccine Antigens. G. V. Quinnan, Jr., ed. Elsevier, New York, pp. 61-67.